Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|20|2883-2890

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.20, 2012-07, pp. : 2883-2890

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase 5 (Cdk5): A Potential Therapeutic Target for the Treatment of Neurodegenerative Diseases and Diabetes Mellitus

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-10 ,pp. : 1070-1074

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

CDK9 a Potential Target for Drug Development

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

CDK9/cyclin T1: a host cell target for antiretroviral therapy

By Klebl Bert M   Choidas Axel  

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 317-330

Future Medicine

Access to resources Recommend Favorite

Cyclin-Dependent Kinase 4/6 (Cdk4/6) Inhibitors: Perspectives in Cancer Therapy and Imaging

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-06 ,pp. : 527-539

Bentham Science Publishers

Access to resources Recommend Favorite